Aromatase inhibitors therapy and major osteoporotic fracture risk in postmenopausal breast cancer patients: a nationwide real-world cohort study.

IF 5.6 1区医学 Q1 Medicine

Breast Cancer Research Pub Date : 2025-05-30 DOI:10.1186/s13058-025-02050-5

Pin-Han Liu, Ching-Fang Tsai, Yu-Chen Hsu, Cheng-Yi Wu, Hsin-Yi Yang

引用次数: 0

Abstract Image

查看原文本刊更多论文

芳香酶抑制剂治疗和绝经后乳腺癌患者骨质疏松性骨折风险：一项全国性的真实世界队列研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Breast Cancer Research ONCOLOGY-

CiteScore

12.00

自引率

0.00%

发文量

审稿时长

12 weeks

期刊介绍： Breast Cancer Research, an international, peer-reviewed online journal, publishes original research, reviews, editorials, and reports. It features open-access research articles of exceptional interest across all areas of biology and medicine relevant to breast cancer. This includes normal mammary gland biology, with a special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal covers preclinical, translational, and clinical studies with a biological basis, including Phase I and Phase II trials.